|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
价值评估 |
盈利(现时/预测)
-4.75/-0.63
|
企业价值
67.57M
|
资产负债 |
每股账面净值
1.07
|
现金流量 |
现金流量率
--
|
损益表 |
收益
500.00K
|
每股收益
3.77
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|

同行比较之报价最少15分钟延迟
业务概览
|
|||
Exicure Inc is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. It operates in a single segment which is Biotechnology. |